Dialog between mantle cell lymphoma cells and lymphoma-associated macrophages underlies ibrutinib resistance

Dialog between mantle cell lymphoma cells and lymphoma-associated macrophages underlies ibrutinib resistance

Introduction: Patients with mantle cell lymphoma (MCL) frequently develop resistance to ibrutinib. Lymphoma-associated macrophages (LAMs) may play a causal role in this resistance but remain underexplored in current literature. Objectives: To elucidate the role of LAMs in mediating ibrutinib resista...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xiaoqing Sun, Caiqin Wang, Jianghua Cao, Jing Li, Gang Ma, Xianqiu Wu, Peng Sun, Yu Wang, Jiajia Huang, Robert Peter Gale, Zhiming Li
Format:	Article
Language:	English
Published:	Elsevier 2025-07-01
Series:	Journal of Advanced Research
Subjects:	BTK inhibitor Resistance Macrophages Mantle cell lymphoma CXCL5 CXCR2
Online Access:	http://www.sciencedirect.com/science/article/pii/S2090123224003667
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Mantle Cell Lymphoma of Intestine Presenting as Multiple Lymphomatous Polyposis with Intussusception
by: Meena N. Jadhav, et al.
Published: (2015-01-01)

An Anaplastic Pleomorphic Variant of Mantle Cell Lymphoma
by: Radu Chiriac, et al.
Published: (2025-06-01)

Ferroptosis-related prognostic model of mantle cell lymphoma
by: Gao Qianwen, et al.
Published: (2024-11-01)

Intermediate Results of Prospective Observational Study: The 2-year Experience of Ibrutinib Therapy in Relapsed/Refractory Mantle Cell Lymphoma in Clinical Practice
by: VI Vorob’ev, et al.
Published: (2019-03-01)

Intestinal mantle cell lymphoma recurring at laparotomy scar region
by: Ray Amitabh, et al.
Published: (2009-12-01)

Efficacy and safety of tirabrutinib monotherapy in relapsed or refractory B-cell lymphomas/leukemia: a meta-analysis
by: Jingfei Wang, et al.
Published: (2025-04-01)

POD24-Based prognostic signature enables personalized risk stratification in mantle cell lymphoma
by: Yizi He, et al.
Published: (2025-03-01)

Synchronous mantle cell lymphoma and prostate adenocarcinoma-is it just a coincidence?
by: Petković Ivan, et al.
Published: (2016-01-01)

Case Report: Membranous nephropathy associated with mantle cell lymphoma: a rare case
by: Mian Ren, et al.
Published: (2025-08-01)

ACUTE RENAL FAILURE DUE TO MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS AND KIDNEY TUMORAL INFILTRATION IN A PATIENT WITH MANTLE CELL LYMPHOMA
by: JULIA montoro
Published: (2014-08-01)

First-Line Treatment of Mantle-Cell Lymphoma: Analysis of Effectiveness and Cost-Effectiveness
by: KD Kaplanov, et al.
Published: (2018-04-01)

Mantle Zone Cell Lymphomas. New Opportunities for Diagnosis and Treatment (Epidemiological Research)
by: E. I. Kankumasheva, et al.
Published: (2020-01-01)

Treatment outcomes for patients with newly diagnosed or relapsed/refractory TP53-mutated mantle cell lymphoma: a systematic review and meta-analysisResearch in context
by: Na Zhang, et al.
Published: (2025-07-01)

Cost-effectiveness analysis of acalabrutinib in treatment of patients with relapsed/refractory form of mantle cell lymphoma who previously received at least one line of therapy
by: S. K. Zyryanov, et al.
Published: (2024-08-01)

Genomic signatures in plasma circulating tumor DNA reveal treatment response and prognostic insights in mantel cell lymphoma
by: Zhou Ouyang, et al.
Published: (2025-05-01)

Upfront Management of Blastoid Variant Mantle Cell Lymphoma: Making the Case for 2nd/3rd‐Generation Bruton Tyrosine Kinase Inhibitor‐Based Therapies
by: Benjamin J. Lee, et al.
Published: (2024-10-01)

Mantle cell lymphoma relapsing at the lymphedematous arm.
by: Giuseppina Massini, et al.
Published: (2013-02-01)

Real-world assessment to estimate multiple attributes related to treatment cost driver for mantle cell lymphoma in Japan by econometric modeling
by: Saaya Tsutsué, et al.
Published: (2025-01-01)

METTL3 regulates Ambra1 expression in an m6A-YTHDF2-dependent manner to promote mantle cell lymphoma progression
by: Shujun Li, et al.
Published: (2025-07-01)

Research progress on the regulation of autophagy in cardiovascular diseases by chemokines
by: Ma Jingfeng, et al.
Published: (2025-06-01)

High expression of CXCL13 predicts a favorable response to immunotherapy by upregulating CXCR5+CD8+ T-cell infiltration in gastric cancer
by: Shuning Xu, et al.
Published: (2025-05-01)

The CXCL12/CXCR4 Axis: An Emerging Therapeutic Target for Chronic Pain
by: Chen Z, et al.
Published: (2025-05-01)

Continuous R-DA-EDOCH alternated with high-dose Ara-C induces deep remission and overcomes high-risk factors in young patients with newly diagnosed mantle cell lymphoma
by: Yi Wang, et al.
Published: (2025-02-01)

Ibrutinib in primary central nervous system diffuse large B-cell lymphoma
by: Justin T Low, et al.
Published: (2020-03-01)

BTK inhibition in primary central nervous system lymphoma: mechanisms, clinical efficacy, and future perspectives
by: Yurou Xing, et al.
Published: (2024-12-01)

Intrinsic immunosuppressive features of monocytes suppress CAR-T19 through IL-1 pathway modulation in mantle cell lymphoma
by: Kun Yun, et al.
Published: (2025-06-01)

The role of CXCL16 in atherosclerosis: from mechanisms to therapy
by: Yue Liu, et al.
Published: (2025-05-01)

Research on the characteristics of 18F-FDG PET/CT in mantle cell lymphoma and the discrimination between cellular morphological variants
by: REN Yixuan, et al.
Published: (2024-12-01)

Integration of single-cell RNA and bulk RNA sequencing revealed malignant ductal cell heterogeneity and prognosis signatures in pancreatic cancer
by: Haiyang Du, et al.
Published: (2025-07-01)

Curcumin inhibits ferroptosis-mediated vascular occlusion by regulating the CXCL10/CXCR3 axis in retinopathy of prematurity
by: Rui Niu, et al.
Published: (2025-03-01)

Modeling Lymphoma Angiogenesis, Lymphangiogenesis, and Vessel Co-Option, and the Effects of Inhibition of Lymphoma–Vessel Interactions with an αCD20-EndoP125A Antibody Fusion Protein
by: Christian Elledge, et al.
Published: (2024-11-01)

The C-X-C Motif Chemokine Ligand 5, Which Exerts an Antioxidant Role by Inducing HO-1 Expression, Is C-X-C Motif Chemokine Receptor 2-Dependent in Human Prostate Stroma and Cancer Cells
by: Kang-Shuo Chang, et al.
Published: (2024-12-01)

CXCL12α/SDF‐1 from perisynaptic Schwann cells promotes regeneration of injured motor axon terminals
by: Samuele Negro, et al.
Published: (2017-05-01)

A phase 2 trial of CXCR4 antagonism and PD1 inhibition in metastatic pancreatic adenocarcinoma reveals recruitment of T cells but also immunosuppressive macrophages
by: Katherine M. Bever, et al.
Published: (2025-12-01)

云芝多糖-B对人食管癌细胞Eca109转移的影响
Published: (2013-01-01)

CXCL12/CXCR4 modulates macrophage efferocytosis to induce glomerular crescent formation and fibrosis via ELMO1/DOCK180/RAC1 signaling in ANCA-associated glomerulonephritis
by: Zilin Liu, et al.
Published: (2025-07-01)

CXCL10-induced regulatory T cells and adenosine signaling promote immunosuppression and progression of epithelial ovarian cancer
by: Annabelle C. Lin, et al.
Published: (2025-07-01)

Mechanism underlying the involvement of CXCR4/CXCL12 in diabetic wound healing and prospects for responsive hydrogel-loaded CXCR4 formulations
by: Lingli Wang, et al.
Published: (2025-04-01)

Correction: Mechanism underlying the involvement of CXCR4/CXCL12 in diabetic wound healing and prospects for responsive hydrogel-loaded CXCR4 formulations
by: Lingli Wang, et al.
Published: (2025-07-01)

The metastatic role of the CXCL10-CXCR3 axis and its therapeutic potential in osteosarcoma
by: Benjamin B. Gyau, et al.
Published: (2025-06-01)